Compound Management Market
Compound Management Market by Type (Product, Service), by Sample Type (Chemical Compounds, Bio Samples), by Application (Drug Discovery, Gene Synthesis, BioBanking, Others), by End User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations, Others), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)
|Forecast Years for Compound Management Market:||2022 - 2028|
|Historical Years for Compound Management Market:||2016 - 2021|
|Revenue 2021 for Compound Management Market:||USD 355.5 Million|
|Revenue 2028 for Compound Management:||USD 897.1 Million|
|Revenue CAGR (2022 - 2028) for Compound Management Market :||16.5%|
|Fastest Growing Region (2022 - 2028) for Compound Management Market:||Asia Pacific|
|Largest Region (2021) for Compound Management Market:||North America|
Compound Management Market: By Type, Sample Type, Application, End-User and Region
Global Compound Management market is valued at USD 355.5 Million in 2021 and is projected to attain a value of USD 897.1 Million by 2028 at a CAGR of 16.5% during the forecast period, 2022–2028. Bio-pharmaceuticals are the pharmaceutical industry's fastest-growing category. The sample management market will benefit from this sector's expansion, as increasing biologic output will raise need for sample management. The increasing demand for biologics, the emergence of biosimilars, and increased R&D expenditure in bio-pharmaceutical businesses, as well as the rising frequency of chronic diseases, are all contributing to the expansion of the bio-pharmaceuticals market. Furthermore, by focusing on outsourcing functions to CROs and CMOs, most biotech and bio-pharma businesses have been able to focus on their core competencies.
The recent outbreak of COVID-19 has prompted Compound Management solution vendors to respond fast in order to meet the growing need for high-quality virus protection services. COVID-19 has engulfed the whole healthcare ecosystem, from pharmaceutical corporations to medicine producers to COVID-19 vaccine developers to health insurance and hospitals, thanks to its rapid expansion. During this time, applications like telemedicine, remote patient monitoring, and interactive medicine, as well as inpatient monitoring, are projected to gain popularity.
Expansion of Pharma & Bio-pharma Manufacturing in Emerging Markets
Emerging markets like India and China are likely to become important manufacturing hubs for pharma and biotech. Low labor and raw material costs, expanding life science research, government assistance, and technological integration and breakthroughs are all factors. Various Asian governments have set aside considerable sums of money to stimulate research in the bio sciences business.
For example, the Indian government declared in 2014 that it will invest up to USD 5 billion per year for the following five years to enhance the country's biotechnology sector. The Department of Biotechnology (DBT) is collaborating with government-funded organisations such as the National Biotechnology Board (NBTB) to make India a global powerhouse for biotechnology research.
Large Capital Investments Required
Building a compound/sample management facility necessitates significant capital expenditures in both hardware and software, such as the installation of new automated liquid compound storage systems linked to a comprehensive inventory database. A large automated storage system, for example, can cost anywhere between $1 million and $10 million. Small and medium-sized pharmaceutical enterprises may be unable to afford such facilities due to the significant capital needs. Such devices are also difficult to get by for research centers with restricted funds. As a result, manual storage systems continue to be chosen by these end-users.
Global Compound Management market is segmented on the basis of Type into Product and Service. By Sample type into Chemical Compounds and Bio Samples. By Application into Drug Discovery, Gene Synthesis, Bio-banking and Others. By End Use into Pharmaceutical Companies, Bio-pharmaceutical Companies, Contract Research Organizations and Others. Based on region, the Compound Management market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Below tree is interactive. You can click the nodes to get more information.
North America to Continue Dominating the Compound Management Market
The North America is expected to dominate the market over the forecast period. This is attributable to the large number of pharmaceutical and biotechnology businesses engaged in drug development. As a result, there is a growing need for services in this area. Furthermore, as disease-related morbidity and mortality have increased, more medication candidates have been discovered, fueling this region's rise.
Key players operating in the Compound Management market are: Brooks Life Sciences (US), Titian Software Limited (UK), Beckman Coulter Inc (US), Hamilton Company (US) , Evotec (Germany).
The Compound Management market is segmented as follows:
The Compound Management market scope can be tabulated as below:
Frequently Asked Questions
the global demand for Compound Management
in terms of revenue?
The global Compound Management valued at USD 355.5 Million in 2020 and is expected to reach USD 897.1 Million in 2028 growing at a CAGR of 16.5%
are the prominent players
in the market?
The prominent players in the market are Brooks Life Sciences (US), Titian Software Limited (UK), Beckman Coulter Inc (US), Hamilton Company (US) , Evotec (Germany)..
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 16.5% between 2021 and 2028.
the driving factors
fueling the growth of the market.
The driving factors of the Compound Management include
- Expansion of Pharma & Biopharma Manufacturing in Emerging Markets
region accounted for the
largest share in the market?
North America was the leading regional segment of the Compound Management in 2020.